期刊文献+

2013~2017年海南医学院第二附属医院无乳链球菌的临床分布及耐药性分析 被引量:2

Clinical distribution and drug resistance of Streptococcus agalactiae from 2013 to 2017 in the Second Affiliated Hospital of Hainan Medical University
下载PDF
导出
摘要 目的探讨无乳链球菌的临床分布和耐药性,为预防临床感染和指导临床合理用药提供依据。方法收集2013年1月~2017年12月海南医学院第二附属医院门诊及住院患者各类临床标本。采用WHONET 5.6软件统计分析无乳链球菌引起感染的类型和耐药性,并对红霉素耐药、克林霉素敏感或中介的无乳链球菌做D-抑菌圈试验。结果共检出无乳链球菌261株,检出率逐年呈上升趋势。其主要集中分布于妇产科、门诊和泌尿外科。主要来源于阴道分泌物,其次是清洁中段尿和伤口分泌物。无乳链球菌对青霉素、氨苄西林、万古霉素和利奈唑胺均未发现耐药株;对头孢噻肟、对头孢吡肟和头孢曲松的耐药率较低;而对克林霉素、红霉素、阿奇霉素、四环素耐药率较高。结论无乳链球菌感染最常见于泌尿生殖系统感染和软组织感染,青霉素和其他β-内酰胺类药物可作为无乳链球菌感染经验用药的首选药物。另外,加做D-抑菌圈试验可有效避免不合理使用克林霉素,并根据药敏试验结果合理选用抗菌药物进行预防与治疗。 Objective To investigate the clinical distribution and drug resistance of Streptococcus agalactiae, and to provide evidence for preventing clinical infection and guiding clinical rational drug use. Methods All kinds of clinical specimens were collected from outpatient and inpatient patients of the Second Affiliated Hospital of Hainan Medical College from January 2013 to December 2017. WHONET 5.6 software was used to statistically analyze the types of infection and drug resistance caused by Streptococcus agalactiae, and to conduct the D-Bacteriostatic circle test for Streptococcus agalactiae with Erythromycin resistance, Clindamycin sensitivity or intermediate. Results A total of 261 strains of Streptococcus agalactiae were detected, and the detection rate was increasing year by year. Mainly distributed in obstetrics and gynecology, outpatient and urology. Mainly from vaginal secretions, followed by cleaning midstream urine and wound secretions. No resistant strains to Penicillin, Ampicillin, Vancomycin and Linezolid were found. The drug resistance rates of Cefotaxime, Cefepime and Ceftriaxone were low. And Clindamycin, Erythromycin, Azithromycin, Tetracycline resistance rate were high. Conclusion Streptococcus agalactiae infections are most common in urinary and reproductive system infections and soft tissue infections, and Penicillin and other β-lactamides can be used as the first choice of empiric agents for Streptococcus agalactiae infections. In addition, the addition of D-circle test can effectively avoid the unreasonable use of Clindamycin, and according to the drug sensitivity test results, the rational selection of antimicrobial agents for prevention and treatment.
作者 廉芳 林翀 陈少文 苏应仙 陈伟彬 陈林 LIAN Fang;LIN Chong;CHEN Shaowen;SU Yingxian;CHEN Weibin;CHEN Lin(Department of Clinical Laboratory, the Second Affiliated Hospital of Hainan Medical University, Hainan Province, Haikou 570311, China)
出处 《中国医药导报》 CAS 2019年第19期152-155,159,共5页 China Medical Herald
基金 海南省科协青年科技英才学术创新计划项目(HAST201637) 海南省卫生厅医学科研课题项目(琼卫2013资助-058号)
关键词 无乳链球菌 耐药性 感染 Streptococcus agalactiae Drug resistance Infection
  • 相关文献

参考文献16

  • 1陈惠玲,叶惠芬,邓家德,陈英姿,龙幼敏.B族链球菌皮肤软组织及创伤感染分离株的耐药基因检测[J].国际检验医学杂志,2010,31(10):1057-1058. 被引量:6
  • 2胡利春,邹洁洁,陈海燕.晚期孕妇生殖道感染无乳链球菌与新生儿感染的相关性研究[J].中国微生态学杂志,2014,26(7):836-838. 被引量:26
  • 3胡付品,朱德妹,汪复,蒋晓飞,孙自镛,陈中举,胡志东,李金,谢轶,康梅,徐英春,张小江,张朝霞,季萍,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,储云卓,田素飞,徐元宏,沈继录,单斌,杜艳,卓超,苏丹虹,张泓,孔菁,魏莲花,吴玲,胡云建,艾效曼.2013年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2014,14(5):365-374. 被引量:615
  • 4胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,韩艳秋,郭素芳,魏莲花,吴玲,张泓,孔菁,胡云建,艾效曼,卓超,苏丹虹.2014年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2015,15(5):401-410. 被引量:722
  • 5胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,吴玲,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,汪瑞忠,房华,俞碧霞,赵勇,龚萍.2015年CHINET细菌耐药性监测[J].中国感染与化疗杂志,2016,16(6):685-694. 被引量:382
  • 6胡付品,郭燕,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,邹凤梅,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,汪瑞忠,房华,俞碧霞,赵勇,龚萍,郭大文,赵金英,刘文恩,李艳明,金炎,邵春红,温开镇,张贻荣,徐雪松,鄢超,喻华,黄湘宁,王山梅,楚亚菲,张利侠,马娟,周树平,周艳,朱镭,孟晋华.2016年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2017,17(5):481-491. 被引量:618
  • 7胡付品,郭燕,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,邹凤梅,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,汪瑞忠,房华,俞碧霞,赵勇,龚萍,郭大文,赵金英,刘文恩,李艳明,金炎,邵春红,温开镇,张贻荣,徐雪松,鄢超,喻华,黄湘宁,王山梅,楚亚菲,张利侠,马娟,周树平,周艳,朱镭,孟晋华,董芳,郑红艳,沈瀚,周万青,贾伟,李刚,吴劲松,卢月梅.2017年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2018,18(3):241-251. 被引量:469
  • 8时春艳,杨慧霞.B族溶血性链球菌围产期感染的预防和处理策略[J].中华围产医学杂志,2008,11(5):315-318. 被引量:21
  • 9林宇岚,陈守涛,荀振,张泽佳,闫翔宇,郭少英,留玉芬,高丽钦,甘龙杰,黄尔,欧启水,杨滨.179株无乳链球菌的标本分布及耐药性分析[J].国际检验医学杂志,2015,36(10):1376-1378. 被引量:16
  • 10曹雪萍,张贤华,陈慧芬,沈平华.2015年至2017年上海地区无乳链球菌临床感染情况及耐药性分析[J].诊断学理论与实践,2018,17(3):308-310. 被引量:10

二级参考文献111

  • 1朱敏,范建霞,程利南.围产期B族链球菌感染的研究进展[J].中华妇产科杂志,2005,40(2):137-141. 被引量:110
  • 2申阿东,张桂荣,王咏红,杨永弘.B组链球菌的耐药性及红霉素耐药基因检测研究[J].中华儿科杂志,2005,43(9):661-664. 被引量:15
  • 3邓江红,姚开虎,胡惠丽,俞桑洁,高薇,伏利兵,何乐健,Alexander Dmitriev,杨永弘.新生儿肺炎死亡病例中B族链球菌的检测[J].中华儿科杂志,2006,44(11):850-854. 被引量:53
  • 4ACOG Committee opinin. Prevention of early-onset group B streptococcal disease in newborns. Number 173. Washington DC: American College of Obstetricians and Gynecologists. 1996.
  • 5Centers for Disease Control (CDC):Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR,1996, 45(RR7) :1-24.
  • 6Schrag S, Gorwitz R, Fultz - Butts K, et al. Prevention of perinatal group B streptococcal disease. MMWR Recomm Rep, 2002, 51:1-22.
  • 7Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations United States, 2003-2005. MMWR Morb Mortal Wkly Rep, 2007,56 : 701-705.
  • 8Barcaite E, Bartusevicius A, Tameliene R, et al. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet Gynecol Scand, 2008,87:260-271.
  • 9Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol, 1996, 88:811-815.
  • 10Hamada S, Vearncombe M, McGeer A, et al. Neonatal group B streptococcal disease.- incidence, presentation, and mortality. J Matern Fetal Neonatal Med, 2008,21 : 53-57.

共引文献2491

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部